SANACARE NUTRITION ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  3.7% 3.7% 3.7% 3.7% 3.7%  
Bankruptcy risk  1.2% 1.8% 2.0% 5.3% 1.6%  
Credit score (0-100)  83 71 67 42 73  
Credit rating  A A A BBB A  
Credit limit (kDKK)  54.2 0.8 0.3 0.0 10.4  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Gross profit  1,411 1,557 1,632 1,340 3,520  
EBITDA  480 155 204 -269 2,005  
EBIT  449 130 196 -278 1,979  
Pre-tax profit (PTP)  457.0 129.0 155.8 -259.7 1,990.5  
Net earnings  356.0 99.0 119.3 -268.5 1,611.9  
Pre-tax profit without non-rec. items  457 129 156 -260 1,990  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Tangible assets total  36.0 11.0 3.3 145 119  
Shareholders equity total  1,300 1,399 1,519 1,250 2,862  
Interest-bearing liabilities  26.0 5.0 0.0 0.0 0.0  
Balance sheet total (assets)  2,543 2,872 3,358 3,503 5,284  

Net Debt  -660 -721 -783 -354 -949  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,411 1,557 1,632 1,340 3,520  
Gross profit growth  35.2% 10.3% 4.8% -17.9% 162.6%  
Employees  2 4 4 4 3  
Employee growth %  0.0% 100.0% 0.0% 0.0% -25.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  2,543 2,872 3,358 3,503 5,284  
Balance sheet change%  43.7% 12.9% 16.9% 4.3% 50.9%  
Added value  480.0 155.0 204.1 -269.8 2,004.6  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -63 -50 -16 181 -100  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 -1.0 1.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  31.8% 8.3% 12.0% -20.7% 56.2%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  21.5% 5.0% 6.5% -5.3% 45.8%  
ROI %  39.3% 9.8% 13.8% -13.2% 97.6%  
ROE %  31.7% 7.3% 8.2% -19.4% 78.4%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  51.1% 48.7% 46.9% 35.7% 54.6%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -137.5% -465.2% -383.7% 131.4% -47.3%  
Gearing %  2.0% 0.4% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  16.7% 45.2% 1,849.8% 0.0% 0.0%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  1.3 1.3 1.0 0.8 1.1  
Current Ratio  2.1 1.9 1.8 1.5 2.1  
Cash and cash equivalent  686.0 726.0 783.0 354.0 948.6  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  1,311.0 1,388.0 1,515.3 1,057.4 2,759.3  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  240 39 51 -67 668  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  240 39 51 -67 668  
EBIT / employee  225 33 49 -69 660  
Net earnings / employee  178 25 30 -67 537